European Journal of Gynaecological Oncology
Print ISSN: 0392-2936 | Online ISSN: 2709-0086
European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal. EJGO publishes on a broad range of gynaecologic oncology topics. Different types of articles are considered for publication (see Aims & Scope) with emphasis on original research to include prospective clinical trials, basic and applied science, case-control, and cohort studies. We also encouraged the submission of systematic reviews and meta-analyses.
Articles
Molecular markers and endometrial cancer
Molecular markers and endometrial cancer
DOI: 10.22514/ejgo.2022.051
(This article belongs to the Special Issue Molecular Characterization in Endometrial Cancer: Progress and Prospects )
Feasibility and safety of minimally invasive technology for interval cytoreductive surgery during advanced ovarian cancer after neoadjuvant chemotherapy
Feasibility and safety of minimally invasive technology for interval cytoreductive surgery during advanced ovarian cancer after neoadjuvant chemotherapy
DOI: 10.22514/ejgo.2022.052
(This article belongs to the Special Issue Enhanced Recovery of Gynecological Oncology)
Traditional Chinese medicine for bone metastasis of breast cancer: a systematic review and meta-analysis
Traditional Chinese medicine for bone metastasis of breast cancer: a systematic review and meta-analysis
DOI: 10.22514/ejgo.2022.053
Robot-assisted surgery for early uterine corpus cancer: assessing the learning curve
Robot-assisted surgery for early uterine corpus cancer: assessing the learning curve
DOI: 10.22514/ejgo.2022.054
Vaginal hysterectomy using the ERBE BiClamp® bipolar vessel sealing system as a surgical approach for endometrial cancer—single surgeon experience from a district general hospital
Vaginal hysterectomy using the ERBE BiClamp® bipolar vessel sealing system as a surgical approach for endometrial cancer—single surgeon experience from a district general hospital
DOI: 10.22514/ejgo.2022.055
Application and comparison of several machine learning methods in the prognosis of cervical cancer
Application and comparison of several machine learning methods in the prognosis of cervical cancer
DOI: 10.22514/ejgo.2022.056
Visual analysis of minimally invasive surgery for breast cancer: a bibliometric analysis
Visual analysis of minimally invasive surgery for breast cancer: a bibliometric analysis
DOI: 10.22514/ejgo.2022.057
A random forest-neural network coupled model for predicting the recurrence location of uterine cancer
A random forest-neural network coupled model for predicting the recurrence location of uterine cancer
DOI: 10.22514/ejgo.2022.059
A prognostic signature of six necroptosis-related miRNAs for predicting the overall survival of breast cancer patients
A prognostic signature of six necroptosis-related miRNAs for predicting the overall survival of breast cancer patients
DOI: 10.22514/ejgo.2022.060
Analysis of the drug-target-disease network of trichosanthes-angelica sinensis-frankincense-myrrh in the treatment of breast cancer
Analysis of the drug-target-disease network of trichosanthes-angelica sinensis-frankincense-myrrh in the treatment of breast cancer
DOI: 10.22514/ejgo.2022.061
Uterine lipoleiomyoma misdiagnosed as uterine fibroid in a pregnant woman: a case report and literature review
Uterine lipoleiomyoma misdiagnosed as uterine fibroid in a pregnant woman: a case report and literature review
DOI: 10.22514/ejgo.2022.063
Low-grade serous carcinoma with solid growth pattern: an unusual architecture and potential pitfall
Low-grade serous carcinoma with solid growth pattern: an unusual architecture and potential pitfall
DOI: 10.22514/ejgo.2022.064
Published Ahead of Print
Special Issues
Topic Collection "Current Novel Treatment of Patients with Ovarian Cancer"
Keywords: Ovarian Cancer, Epithelial Ovarian Cancer, Optimal Debulking Surgery, Chemotherapy HIPEC, Platinum-resistant Ovarian Cancer, Anti-angiogenesis, PARP Inhibitors
Editor: Samir A. Farghaly, MD, PhD,Scott M. Eisenkop, MD
Submission deadline: 31 December 2022
Breast Cancer
Keywords: Breast cancer;Systemic treatment;Adjuvant setting;Metastatic setting;Genetic councelling;Triple negative breast cancer;Her2+ Breast cancer;Endocrine treatment
Editor: Michael Friedrich, MD,Nicolò Bertozzi, MD
Submission deadline: 30 April 2022
Systematic Review or Meta-Analysis in Gynaecological Oncology
Keywords: Cervical cancer;Ovarian cancer;Uterine/endometrial cancer;Vulvar cancer;Vaginal cancer;Breast cancer;Gestational trophoblastic disease;Primary peritoneal cancer
Editor: Enrique Hernandez, MD
Submission deadline: 25 April 2022
Gynecological cancer prevention: a new prospective
Keywords: Gynecology; Obstetric and Gynecological Ultrasound; Menopause Obstetrics; Gynecologic Oncology; Gynecologic Pathology
Editor: Ottavia Dʼoria, MD
Submission deadline: 31 October 2023
Molecular pathological approach to uterine mesenchymal tumors and malignant tumors for the establishment of new diagnostic and therapeutic methods
Keywords: Leiomyoma; Leiomyosarcoma; Ovarian cancer; Cervical cancer; Endometrial cancer
Editor: Prof. Takuma Hayashi
Submission deadline: 31 October 2023
Advanced Decision Support Systems for Efficient Diagnosis of Gynaecological Cancers
Keywords: Computational and Mathematical Methods; Gynaecological Cancers; Machine Learning; Optimization Algorithms
Editor: Liaqat Ali, PhD
Submission deadline: 31 October 2022
Polycystic Ovary Syndrome and the Risk of Endometrial Cancer
Keywords: PCOS; Endometrial Hyperplasia; Endometrial Cancer; Unopposed Estrogen Effect; Progesterone Resistance; Endometrial Mesenchymal Stroma/Stem Cells; Obesity; Insulin Resistance; Hyperandrogenism; Inflammation
Editor: Masuma Khatun, PhD
Submission deadline: 24 June 2023
The management of endometrial cancer
Keywords: Endometrial Cancer; High-risk Factors; Adjuvant Treatment; Endocrine Therapy; Targeted Therapy
Editor: Nicolae Gica, MD, PhD,Yoland Antill, BMed FRACP MD
Submission deadline: 31 July 2023
Molecular Characterization in Endometrial Cancer: Progress and Prospects
Keywords: Endometrial Cancer (EC); Molecular Biomarkers; Immune Checkpoint Inhibitor; Precision Medicine
Editor: Andrea Giannini, MD, PhD
Submission deadline: 31 December 2022
Immunotherapy for Gynecological Oncology
Keywords: Cancer immunotherapy;Cancer vaccination;Immune checkpoint inhibitor;Ovarian cancer;Cervical cancer;Endometrial cancer
Editor: Tadahiro Shoji, MD
Submission deadline: 31 July 2021
Featured Article
Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States. DOI: 10.31083/j.ejgo4206181
To Be a Reviewer
If you would like to volunteer to review a manuscript for European Journal of Gynaecological Oncology journal, please click “Review for EJGO” below to register at our submission website or log in our Online Peer Review system. Your name, contact details, and expertise will be automatically added to our database of reviewers.
Review for EJGOJoin Editorial Board
You are welcome to join our editorial board. Our journal produces and issues editorial board certificates for editorial board members, and the journal website will display the names and personal websites of editorial board members to help enhance their scientific influence. Members of the editorial committee are entitled to 1 free publication (both editorial member’s or recommended paper) per year, and other articles over 2 can enjoy 30% discount of publishing fee.
Join Editorial BoardEditor-in-Chief
Prof. Enrique Hernandez, MD, FACOG, FACS.
Dr. Hernandez is the J. Robert Willson Professor and Chair, Obstetrics, Gynecology and Reproductive Sciences of Lewis Katz School of Medicine at Temple University. He is also a professor in Pathology and Laboratory Medicine of Lewis Katz School of Medicine at Temple University. He specializes in comprehensive, compassionate care of women with gynecologic cancer and pre-cancerous conditions, using the most up-to-date and sophisticated diagnostic and treatment tools.